HBT Labs

HBT Labs is a professional pharmaceutical company that leads in developing solutions for complex injectable drugs. The company focuses on drugs with complex chemical and manufacturing processes, and its product pipeline includes generics and 505(b)(2) products targeting various indications, including cancer and central nervous system diseases. HBT Labs has extensive experience in developing proprietary processes and technologies to manufacture complex drugs across multiple delivery platforms, including liposomes, nanoparticles, emulsions, and long-acting injectable suspensions. Additionally, HBT Labs offers a wide range of contract development and manufacturing services (CDMO), assisting in the formulation development tailored to its drug delivery expertise and manufacturing clinical supplies or early-stage products.